chromosomal microarray testing (Agilent technologies)
90
Structured Review
Agilent technologies
chromosomal microarray testing
Chromosomal Microarray Testing, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chromosomal+microarray+testing/pm25329715-29-17-23
Average 90 stars, based on 1 article reviews
Chromosomal Microarray Testing, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chromosomal+microarray+testing/pm25329715-29-17-23
Average 90 stars, based on 1 article reviews
chromosomal microarray testing - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Neurodevelopmental and immunological features in a child presenting 22q13.2 microdeletion. Article Snippet: Neurodevelopmental and Immunological Features in a Child Presenting 22q13.2 Microdeletion Susanne Th€ummler,* Fabienne Giuliano, Houda Karmous-Benailly, Christian Richelme, Arnaud Fernandez, Christine De Georges, and Florence Askenazy University Department of Child and Adolescent Psychiatry, Nice Children’s Hospitals CHU-Lenval, Nice, France Department of Human Genetics, University Hospital of Nice, Nice, France Department of Pediatrics, Nice Children’s Hospitals CHU-Lenval, Nice, France Article Title: A novel homozygous variant in C1QBP causes severe IUGR , edema, and cardiomyopathy in two fetuses Article Snippet: Analysis of DNA extracted from amniotic cells from S1 and chorionic villus sampling from S2 showed no Microarray:Article Title: Neuropsychological profiles of patients with 2q37.3 deletion associated with developmental dyspraxia. Article Snippet: Neuropsychological Profiles of Patients With 2q37.3 Deletion Associated With Developmental Dyspraxia Kaeko Ogura, Kenzo Takeshita, Chikako Arakawa, Keiko Shimojima, and Toshiyuki Yamamoto* Department of Rehabilitation for Brain Functions, Developmental Disability Study Section, Research Institute of National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Japan Department of Behavioral Neurology and Cognitive Neuroscience, Tohoku University Graduate School of Medicine, Sendai, Japan NPO Child Guidance Center, Fukuoka, Japan Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan Tokyo Women’s Medical University Institute for Integrated Medical Sciences, Tokyo, Japan Article Title: Increased TBX6 gene dosages induce congenital cervical vertebral malformations in humans and mice. Article Snippet: © author(s) (or their employer(s)) 2019. no commercial reuse. see rights and permissions.. Published by BMJ.. ABSTRACT Background congenital vertebral malformations (cVMs) manifest with abnormal vertebral morphology. genetic factors have been implicated in cVM pathogenesis, but the underlying pathogenic mechanisms remain unclear in most subjects. Article Title: Increased TBX6 Gene Dosages Induce Congenital Cervical Vertebral Malformations in Humans and Mice Article Snippet: We analyzed clinical data of the subjects with 16p11.2 BP4-BP5 duplications from Baylor Genetics (BG; Houston, USA). .. These subjects were initially investigated by clinical |